Kodo Millet | whatsinit

About

What it is and where it shows up.

Kodo millet (Paspalum scrobiculatum L.) is a minor cereal grain cultivated primarily in India on marginal and dryland soils, valued for its high protein, dietary fibre, polyphenols (ferulic acid, cinnamic acid), and antioxidant content. It is consumed as a gluten-free staple grain and is associated with cardiovascular and glycaemic health benefits.

Safety summary

The regulatory and scientific consensus.

Properly processed kodo millet is safe and nutritious; however, fungal contamination by Aspergillus tamarii and related species can produce cyclopiazonic acid (CPA), the causative toxin of 'kodo poisoning', which presents as nausea and vomiting and may cause acute hepatotoxicity. Effective pre- and post-harvest management—including correct storage to limit fungal growth—is essential to ensure grain safety. No acceptable daily intake (ADI) is established as it is a whole grain food, not a food additive.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
EFSA (European Food Safety Authority) (European Union)	Approved	Kodo millet is not classified as a novel food in the EU Novel Food Catalogue and is treated as a conventional whole grain food ingredient under Regulation (EC) No 178/2002. No specific EFSA scientific opinion has been issued for kodo millet. Mycotoxin contaminant limits (e.g., aflatoxins, ochratoxin A) under EU Regulation No 1881/2006 apply to the grain as for other cereals.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	FSSAI has framed a comprehensive group standard for 15 millets, including Kodo Millet (Kodo), specifying 8 quality parameters: moisture content, uric acid content, extraneous matter, other edible grains, defects, weevilled grains, and immature and shrivelled grains, under the Food Safety and Standards (Food Product Standards and Food Additives) Regulations, 2011. Individual vertical standard for Kodo Millet is also under formulation.source
FDA (Food and Drug Administration) (United States)	Approved	Kodo millet is a whole grain cereal and is not regulated as a food additive in the US. It is not listed in the FDA Substances Added to Food (formerly EAFUS) inventory. No specific GRAS notice exists; it is treated under general whole-grain food ingredient provisions.source

Who should approach with care

Whose guidance would steer them away.

Liver Disease — Cyclopiazonic acid from fungally contaminated kodo millet has been shown to cause acute hepatotoxicity and preneoplastic liver changes in animal models, posing an elevated risk to individuals with pre-existing liver conditions.

Pregnancy — Mycotoxin contamination (cyclopiazonic acid) in improperly stored or processed kodo millet poses a potential risk to pregnant women and the developing fetus; only FSSAI quality-compliant grain should be consumed.

Infants — Infants are more vulnerable to mycotoxin exposure; kodo millet used in complementary or weaning foods must meet FSSAI group standard quality parameters to ensure absence of cyclopiazonic acid contamination.

Ibs — Kodo millet has high dietary fibre content and is considered heavy for digestion; individuals with irritable bowel syndrome (IBS) may experience bloating or digestive discomfort with high or unprocessed intake.

Kidney Disease — Like other millets, kodo millet contains phytic acid and minerals such as phosphorus and oxalates that may need to be moderated in individuals with chronic kidney disease.

Research citations

The sources behind this verdict.

1PubMed. Unlocking the potential of Kodo millet: reviving an indigenous super grain for tomorrow's nutrition, 2024. pubmed.ncbi.nlm.nih.gov
2FSSAI. FSSAI Guidance Note on Millets – Comprehensive Group Standard for 15 Types of Millets, 2023. fssai.gov.in
3PubMed. 'Kodo poisoning': cause, science and management, 2022. pubmed.ncbi.nlm.nih.gov
4PubMed. A Systematic Review and Meta-Analysis of the Potential of Millets for Managing and Reducing the Risk of Developing Diabetes Mellitus, 2021. pmc.ncbi.nlm.nih.gov
5PubMed. Potential risk of acute hepatotoxicity of kodo poisoning due to exposure to cyclopiazonic acid, 2003. pubmed.ncbi.nlm.nih.gov

Independently researched5 citations